Taiwan's Department of Health said Thursday that local patients using the drug Risperdal would not be affected by a ruling in the United States that fined Johnson & Johnson and a subsidiary, the drug's manufacturer, for improperly marketing the drug and downplaying its potential health risks.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Society
Taiwan headline news
05/04/2024 11:12 AM - Business
Agricultural, forced labor products discussed in Taiwan-U.S. trade talks
05/03/2024 10:46 PM - Business
Gas-fired generators to be on grid when nuclear reactor exits: Wang
05/03/2024 10:32 PM - Politics
U.S. lawmakers urge IOC to end 'Chinese Taipei' mandate for Taiwan
05/03/2024 10:30 PM - Society
Man sentenced to 80 months in jail for fatal DUI
05/03/2024 10:21 PM